‘Triple-Threat’ Breakthrough: New Therapy Eradicates Pancreatic Tumors In Preclinical Study

Researchers at the Spanish National Cancer Research Centre (CNIO), led by Dr. Mariano Barbacid, have achieved a significant breakthrough in the treatment of pancreatic ductal adenocarcinoma (PDAC), the most common and deadly form of pancreatic cancer. In a study published in the journal PNAS, the team demonstrated that a new triple-drug combination therapy can completely and ...